Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Sorter
Keyphrases
Type 2 Diabetic Patients
100%
Glucagon-like
100%
Liraglutide
100%
Coronary Microvascular Function
100%
Coronary Flow Reserve
66%
Coronary Microcirculation
66%
Microvascular Endothelial Function
33%
Treatment Difference
16%
Systolic Blood Pressure
16%
High Dose
16%
Short-term Effects
16%
Beneficial Effects
16%
Washout Period
16%
Coronary Artery Disease
16%
Echocardiography
16%
Patient-completed
16%
Treatment Allocation
16%
Poor Prognosis
16%
Coronary Artery
16%
Short-term Treatment
16%
Stenosis
16%
Cardiovascular System
16%
Induced Stress
16%
Glycated Hemoglobin A1c
16%
Treatment Change
16%
Treatment Study
16%
Dipyridamole
16%
Doppler Flow
16%
Microvascular Function
16%
Two-sample T-test
16%
Carry-over Effects
16%
Transthoracic Doppler
16%
Peripheral Microvascular Function
16%
Medicine and Dentistry
Patient with Type 2 Diabetes
100%
Liraglutide
100%
Glucagon Like Peptide 1
100%
Coronary Flow Reserve
66%
Coronary Microcirculation
66%
Endothelial Function
33%
Systolic Blood Pressure
16%
Body Mass Index
16%
Hemoglobin A1c
16%
Epileptic Absence
16%
Coronary Artery Disease
16%
Echocardiography
16%
Drug Megadose
16%
Glycated Hemoglobin
16%
Stenosis
16%
Coronary Artery
16%
Cardiovascular System
16%
Student T Test
16%
Short Course Therapy
16%
Dipyridamole
16%
Biochemistry, Genetics and Molecular Biology
Glucagon-Like Peptide-1
100%
Liraglutide
100%
Coronary Artery Blood Flow
66%
Microcirculation
66%
Systolic Blood Pressure
16%
Drug Megadose
16%
Glycated Hemoglobin
16%
Two Sample t-Test
16%
Immunology and Microbiology
Coronary Artery Blood Flow
100%
Microcirculation
100%
Coronary Artery
50%
Systolic Blood Pressure
25%
Drug Megadose
25%
Cardiovascular System
25%